Myrexis, Inc. (MYRX) Research

Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.

Market snapshot

Symbol
MYRX
Price
$0.00
Day change
0.00%
Market cap
$27.6K
P/E ratio
-0.00x
52-week range
0.0001-0.005
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • All American Pet Company, Inc. (AAPT)
  • Atlantica, Inc. (ALDA)
  • China Dongsheng International, Inc. (CDSG)
  • China Health Management Corp. (CNHC)
  • Jade Art Group Inc. (JADA)
  • Lotus Pharmaceuticals, Inc. (LTUS)
  • C2E Energy, Inc. (OOGI)
  • One World Ventures, Inc. (OWVI)

Recent insider activity

  • COUCHMAN JONATHAN — trade (0 shares) on 2013-01-22
  • HENDERSON JOHN T — M-Exempt (2500 shares) on 2013-01-18
  • HENDERSON JOHN T — M-Exempt (7500 shares) on 2013-01-18
  • HENDERSON JOHN T — M-Exempt (7500 shares) on 2013-01-18
  • HENDERSON JOHN T — M-Exempt (7500 shares) on 2013-01-18

Open Myrexis, Inc. (MYRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.